A petition by abortion access advocates is eligible for signature gathering, a judge ruled, as advocates work to get rights enshrined in the Nevada constitution.
Health
The Southern Nevada Health District is calling attention to xylazine, an animal tranquilizer being increasingly linked to overdose deaths around the country.
Nevada and three others states are the only ones in which all counties are experencing low levels of the virus.
Most metrics have been on the rise for months, but the rate of the increase has gone up in recent weeks.
The increases in environmental health inspection and permitting fees would deal a crushing blow to businesses struggling to get back on their feet, critics say.
The positivity rate in Clark County fell below 10 percent for the first time this year on Friday, amid another day of declining averages.
Clark County’s major COVID-19 metrics have dropped consistently for nearly a week, providing more evidence that the county has already hit the peak of the current surge.
The Southern Nevada Health District on Thursday reported 515 new COVID-19 cases and nine additional deaths in Clark County during the preceding day.
Both metrics were up over the preceding three days, while deaths and the test positivity rate in the county added to recent improvements, local and state data show.
The county hit the milestone a week after it surpassed 5,000 COVID-19 deaths.
The Silver State’s vaccination rate, though nothing to brag about, is nearer the middle of the pack than the bottom. So what else might be behind the surge in COVID-19 cases?
Nevada on Friday reported 804 new coronavirus cases and three additional deaths, according to data from the Department of Health and Human Services.
Vaccination events at the “Welcome to Fabulous Las Vegas” sign and at a strip club signal a new phase of the inoculation campaign in Southern Nevada.
More than a million first doses of the COVID-19 vaccines have been administered in Clark County, the Southern Nevada Health District announced in a press release Tuesday.
Moderna said it will submit data to the U.S. Food and Drug Administration and other global regulators early next month for authorization to be used starting at age 12.